{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:23:33Z","timestamp":1782962613034,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10067-022-06282-0","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T08:02:40Z","timestamp":1658131360000},"page":"3345-3353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-548X","authenticated-orcid":false,"given":"Risa","family":"Wakiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyo","family":"Ueeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusaku","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Mizusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Mino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"6282_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(13)60889-2","volume":"382","author":"G Murphy","year":"2013","unstructured":"Murphy G, Lisnevskaia L, Isenberg D (2013) Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment. Lancet 382:809\u2013818","journal-title":"Lancet"},{"key":"6282_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M (2019) Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 96:1\u201313","journal-title":"J Autoimmun"},{"key":"6282_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/ard.2009.117200","volume":"69","author":"M Mosca","year":"2010","unstructured":"Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R et al (2010) European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 69:1269\u20131274","journal-title":"Ann Rheum Dis"},{"key":"6282_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736\u2013745","journal-title":"Ann Rheum Dis"},{"key":"6282_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3899\/jrheum.150437","volume":"43","author":"L Durcan","year":"2016","unstructured":"Durcan L, Winegar DA, Connelly MA, Otvos JD, Magder LS, Petri M (2016) Longitudinal evaluation of lipoprotein parameters in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy. J Rheumatol 43:745\u2013750","journal-title":"J Rheumatol"},{"key":"6282_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.mayocp.2019.01.044","volume":"94","author":"G Katz","year":"2019","unstructured":"Katz G, Smilowitz NR, Blazer A, Clancy R, Buyon JP, Berger JS (2019) Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients. Mayo Clin Proc 94:1436\u20131443","journal-title":"Mayo Clin Proc"},{"key":"6282_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/1756-185X.13159","volume":"21","author":"H Babary","year":"2018","unstructured":"Babary H, Liu X, Ayatollahi Y, Chen XP, Doo L, Uppaluru LK et al (2018) Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Int J Rheum Dis 21:84\u201392","journal-title":"Int J Rheum Dis"},{"key":"6282_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/jcm8060796","volume":"8","author":"DH Yang","year":"2019","unstructured":"Yang DH, Leong PY, Sia SK, Wang YH, Wei JC (2019) Long-term hydroxychloroquine therapy and risk of coronary artery disease in patients with systemic lupus erythematosus. J Clin Med 8:796","journal-title":"J Clin Med"},{"key":"6282_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","volume":"77","author":"C Rempenault","year":"2018","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J et al (2018) Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 77:98\u2013103","journal-title":"Ann Rheum Dis"},{"key":"6282_CR10","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","volume":"58","author":"MCM Wasko","year":"2015","unstructured":"Wasko MCM, McClure CK, Kelsey SF, Huber K, Orchard T, Toledo FGS (2015) Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia 58:2336\u20132343","journal-title":"Diabetologia"},{"key":"6282_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/dom.14333","volume":"23","author":"FGS Toledo","year":"2021","unstructured":"Toledo FGS, Miller RG, Helbling NL, Zhang Y, DeLany JP (2021) The effects of hydroxychloroquine on insulin sensitivity, insulin clearance and inflammation in insulin-resistant adults: a randomized trial. Diabetes Obes Metab 23:1252\u20131261","journal-title":"Diabetes Obes Metab"},{"key":"6282_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/03009749609069986","volume":"25","author":"M Petri","year":"1996","unstructured":"Petri M (1996) Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. Scand J Rheumatol 25:191\u2013193","journal-title":"Scand J Rheumatol"},{"key":"6282_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/0961203306071872","volume":"15","author":"G Ruiz-Irastorza","year":"2006","unstructured":"Ruiz-Irastorza G, Egurbide M-V, Pijoan J-I, Garmendia M, Villar I, Martinez-Berriotxoa A, Erdozain J-G, Aguirre C (2006) Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15:577\u2013583","journal-title":"Lupus"},{"key":"6282_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0961203317739129","volume":"27","author":"CC Mok","year":"2018","unstructured":"Mok CC, Tse SM, Chan KL, Ho LY (2018) Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort. Lupus 27:722\u2013727","journal-title":"Lupus"},{"key":"6282_CR15","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686","journal-title":"Arthritis Rheum"},{"key":"6282_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH et al (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771\u20131782","journal-title":"Ann Rheum Dis"},{"key":"6282_CR17","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR et al (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550\u20132558","journal-title":"N Engl J Med"},{"key":"6282_CR18","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","volume":"75","author":"K Franklyn","year":"2016","unstructured":"Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L et al (2016) Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615\u20131621","journal-title":"Ann Rheum Dis"},{"key":"6282_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","volume":"125","author":"J Albrecht","year":"2005","unstructured":"Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S et al (2005) The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 125:889\u2013894","journal-title":"J Invest Dermatol"},{"key":"6282_CR20","doi-asserted-by":"publisher","first-page":"32584","DOI":"10.1073\/pnas.1922169117","volume":"117","author":"X Li","year":"2020","unstructured":"Li X, Zhang D, Vatner DF, Goedeke L, Hirabara SM, Zhang Y et al (2020) Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice. Proc Natl Acad Sci U S A 117:32584\u201332593","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6282_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/JME-17-0096","volume":"59","author":"P Ahlstrom","year":"2017","unstructured":"Ahlstrom P, Rai E, Chakma S, Cho HH, Rengasamy P, Sweeney G (2017) Adiponectin improves insulin sensitivity via activation of autophagic flux. J Mol Endocrinol 59:339\u2013350","journal-title":"J Mol Endocrinol"},{"key":"6282_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fphar.2019.00855","volume":"10","author":"X Qiao","year":"2019","unstructured":"Qiao X, Zhou ZC, Niu R, Su YT, Sun Y, Liu HL et al (2019) Hydroxychloroquine improves obesity-associated insulin resistance and hepatic steatosis by regulating lipid metabolism. Front Pharmacol 10:855","journal-title":"Front Pharmacol"},{"key":"6282_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-020-00236-x","volume":"8","author":"JI Gamez-Nava","year":"2020","unstructured":"Gamez-Nava JI, Diaz-Rizo V, Perez-Guerrero EE, Mu\u00f1oz-Valle JF, Salda\u00f1a-Cruz AM, Fajardo-Robledo NS et al (2020) Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study. Biomark Res 8:55","journal-title":"Biomark Res"},{"key":"6282_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/cei.12473","volume":"179","author":"J Hutcheson","year":"2015","unstructured":"Hutcheson J, Ye Y, Han J, Arriens C, Saxena R, Li QZ et al (2015) Resistin as a potential marker of renal disease in lupus nephritis: an adipokine marker in lupus nephritis. Clin Exp Immunol 179:435\u2013443","journal-title":"Clin Exp Immunol"},{"key":"6282_CR25","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1002\/art.39196","volume":"67","author":"H Chen","year":"2015","unstructured":"Chen H, Shi B, Feng X, Kong W, Chen W, Geng L et al (2015) Leptin and neutrophil-activating peptide 2 promote Mesenchymal stem cell senescence through activation of the phosphatidylinositol 3-kinase\/Akt pathway in patients with systemic lupus Erythematosus. Arthritis Rheumatol 67:2383\u20132393","journal-title":"Arthritis Rheumatol"},{"key":"6282_CR26","doi-asserted-by":"publisher","first-page":"e0184056","DOI":"10.1371\/journal.pone.0184056","volume":"12","author":"V Diaz-Rizo","year":"2017","unstructured":"Diaz-Rizo V, Bonilla-Lara D, Gonzalez-Lopez L, Sanchez-Mosco D, Fajardo-Robledo NS, Perez-Guerrero EE et al (2017) Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis. PLoS ONE 12:e0184056","journal-title":"PLoS ONE"},{"key":"6282_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/RHU.0000000000000580","volume":"23","author":"AA Dini","year":"2017","unstructured":"Dini AA, Wang P, Ye DQ (2017) Serum adiponectin levels in patients with systemic lupus erythematosus: a meta-analysis. J Clin Rheumatol 23:361\u2013367","journal-title":"J Clin Rheumatol"},{"key":"6282_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cyto.2018.08.002","volume":"111","author":"D Chougule","year":"2018","unstructured":"Chougule D, Nadkar M, Venkataraman K, Rajadhyaksha A, Hase N, Jamale T et al (2018) Adipokine interactions promote the pathogenesis of systemic lupus erythematosus. Cytokine 111:20\u201327","journal-title":"Cytokine"},{"key":"6282_CR29","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10067-015-2955-5","volume":"34","author":"Q Huang","year":"2015","unstructured":"Huang Q, Tao SS, Zhang YJ, Zhang C, Li LJ, Zhao W et al (2015) Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 34:1713\u20131720","journal-title":"Clin Rheumatol"},{"key":"6282_CR30","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar2366","volume":"10","author":"K Almehed","year":"2008","unstructured":"Almehed K, d\u2019Elia HF, Bokarewa M, Carlsten H (2008) Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther 10:R15","journal-title":"Arthritis Res Ther"},{"key":"6282_CR31","doi-asserted-by":"publisher","unstructured":"Yan C, Yu L, Zhang XL, Shang JJ, Ren J, Fan J et al (2020) Cytokine profiling in Chinese SLE patients: correlations with renal dysfunction. J Immunol Res 2020:8146502. https:\/\/doi.org\/10.1155\/2020\/8146502","DOI":"10.1155\/2020\/8146502"},{"key":"6282_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2016.08.001","volume":"185","author":"S Soliman","year":"2017","unstructured":"Soliman S, Mohan C (2017) Lupus nephritis biomarkers. Clin Immunol 185:10\u201320","journal-title":"Clin Immunol"},{"key":"6282_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","volume":"133","author":"M Filkova","year":"2009","unstructured":"Filkova M, Haluz\u0131k M, Gay S, Senolt L (2009) The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 133:157\u2013170","journal-title":"Clin Immunol"},{"key":"6282_CR34","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1111\/febs.15322","volume":"287","author":"D Tripathi","year":"2020","unstructured":"Tripathi D, Kant S, Pandey S, Ehtesham NZ (2020) Resistin in metabolism, inflammation, and disease. FEBS J 287:3141\u20133149","journal-title":"FEBS J"},{"key":"6282_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2741\/4758","volume":"24","author":"RT Atawia","year":"2019","unstructured":"Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW (2019) Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci (Landmark Ed) 24:890\u2013934","journal-title":"Front Biosci (Landmark Ed)"},{"key":"6282_CR36","first-page":"29","volume":"3","author":"SS Pang","year":"2006","unstructured":"Pang SS, Le YY (2006) Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 3:29\u201334","journal-title":"Cell Mol Immunol"},{"key":"6282_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mad.2019.01.004","volume":"178","author":"E Acquarone","year":"2019","unstructured":"Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P (2019) Resistin: a reappraisal. Mech Ageing Dev 178:46\u201363","journal-title":"Mech Ageing Dev"},{"key":"6282_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4093\/dmj.2013.37.6.404","volume":"37","author":"HK Park","year":"2013","unstructured":"Park HK, Ahima RS (2013) Resistin in rodents and humans. Diabetes Metab J 37:404\u2013414","journal-title":"Diabetes Metab J"},{"key":"6282_CR39","first-page":"1","volume":"15","author":"K Vuolteenaho","year":"2021","unstructured":"Vuolteenaho K, Tuure L, Nieminen R, Laasonen L, Leirisalo-Repo M, Moilanen E et al (2021) Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab. Scand J Rheumatol 15:1\u20136","journal-title":"Scand J Rheumatol"},{"key":"6282_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0961203316646463","volume":"26","author":"FMM Santos","year":"2017","unstructured":"Santos FMM, Telles RW, Lanna CCD, Teixeira AL, Miranda AS, Rocha NP et al (2017) Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus. Lupus 26:10\u201316","journal-title":"Lupus"},{"key":"6282_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","volume":"23","author":"RI Fox","year":"1993","unstructured":"Fox RI (1993) Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 23:82\u201391","journal-title":"Semin Arthritis Rheum"},{"key":"6282_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16:155\u2013166","journal-title":"Nat Rev Rheumatol"},{"key":"6282_CR43","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.acthis.2016.06.002","volume":"118","author":"AA Abdel-Hamid","year":"2016","unstructured":"Abdel-Hamid AA, Firgany AE (2016) Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines. Acta Histochem 118:560\u2013573","journal-title":"Acta Histochem"},{"key":"6282_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI37273","volume":"119","author":"M Qatanani","year":"2009","unstructured":"Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 119:531\u2013539","journal-title":"J Clin Invest"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06282-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06282-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06282-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T10:11:28Z","timestamp":1665742288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06282-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6282"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06282-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of Kagawa University (Heisei30-047) and was prospectively registered. All participants gave written informed consent prior to entering the study. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}